Human chorionic gonadotropin (hCG) glycoforms change as pregnancy progresses. We have developed an antibody (B152) which can measure a hyperglycosylated early pregnancy isoform of hCG. This putative hyperglycosylated form of hCG arises very early in pregnancies and is rapidly replaced by an isoform that predominates for the remainder of the pregnancy. The profiles of these hCG glycoforms are measured as a ratio of values of two immunometric assays. The profiles of these ratios differ between pregnancies which persist and those which will experience early failure. In this report, daily urine hCG isoform ratios from donor eggs (no exogenous hCG pretreatment), in vitro fertilization pregnancies were profiled and analyzed from the first day following embryo transfer (ET). Significant differences were found between continuing pregnancy and pregnancy loss throughout days 5-20 post-ET. When hCG isoform ratios were analyzed from the first day of detectable hCG, pregnancy loss could be predicted in the case of a single fetus both during the 5- to 10-day time segment (P=0.018) and the 10- to 15-day time segment (P=0.045). When single and multiple fetus pregnancies were analyzed together significance was approached in the 10- to 15-day time period (P=0.058). In a second population of pregnant women who conceived naturally, in whom urine samples were collected at approximately weekly intervals to either term birth or clinical spontaneous abortion, the ratio could discriminate between miscarriages and normal term pregnancies (P=0.043). In later pregnancy, the ratio of hCG isoforms declined more rapidly in miscarriages than in term pregnancy. Antibody B152 was produced using a choriocarcinoma-derived hCG (C5), which was hyperglycosylated at both N- and O-linked sites and was 100% nicked at position beta(47-48). Western blot analyses supported the assay results showing that early pregnancy urine does not contain nicked C5-like hCG. Also, the early pregnancy hCG appeared to be the same size as later pregnancy hCG as judged by SDS gel electrophoresis. A series of Western blot analyses and immunoassays conducted with the samples either non-reduced or reduced showed that B152 is directed to a linear epitope located in the COOH-terminal peptide region of the beta subunit. This indicated that only the O-glycan groups and not the N-linked glycans are part of the antibody epitope.

This article has been cited by other articles:

				S.F. de Medeiros and R.J. Norman Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights Hum. Reprod. Update, January 1, 2009; 15(1): 69 - 95. [Abstract] [Full Text] [PDF]

				M. R Rubin, J. P Bilezikian, S. Birken, and S. J Silverberg Human chorionic gonadotropin measurements in parathyroid carcinoma Eur. J. Endocrinol., October 1, 2008; 159(4): 469 - 474. [Abstract] [Full Text] [PDF]

				K. Handschuh, J. Guibourdenche, V. Tsatsaris, M. Guesnon, I. Laurendeau, D. Evain-Brion, and T. Fournier Human Chorionic Gonadotropin Produced by the Invasive Trophoblast But Not the Villous Trophoblast Promotes Cell Invasion and Is Down-Regulated by Peroxisome Proliferator-Activated Receptor-{gamma} Endocrinology, October 1, 2007; 148(10): 5011 - 5019. [Abstract] [Full Text] [PDF]

				L. Valmu, H. Alfthan, K. Hotakainen, S. Birken, and U.-H. Stenman Site-specific glycan analysis of human chorionic gonadotropin {beta}-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry Glycobiology, December 1, 2006; 16(12): 1207 - 1218. [Abstract] [Full Text] [PDF]

				U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu The classification, functions and clinical use of different isoforms of HCG Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784. [Abstract] [Full Text] [PDF]

				P. Lohstroh, H. Dong, J. Chen, N. Gee, X. Xu, and B. Lasley Daily Immunoactive and Bioactive Human Chorionic Gonadotropin Profiles in Periimplantation Urine Samples Biol Reprod, July 1, 2006; 75(1): 24 - 33. [Abstract] [Full Text] [PDF]

				M. J.N. Weinans, U. Sancken, R. Pandian, J. M.W. van de Ouweland, H. W.A. de Bruijn, J. P. Holm, and A. Mantingh Invasive Trophoblast Antigen (Hyperglycosylated Human Chorionic Gonadotropin) as a First-Trimester Serum Marker for Down Syndrome Clin. Chem., July 1, 2005; 51(7): 1276 - 1279. [Full Text] [PDF]

				R. McChesney, A. J. Wilcox, J. F. O'Connor, C. R. Weinberg, D. D. Baird, J. P. Schlatterer, D.R. McConnaughey, S. Birken, and R. E. Canfield Intact HCG, free HCG {beta} subunit and HCG {beta} core fragment: longitudinal patterns in urine during early pregnancy Hum. Reprod., April 1, 2005; 20(4): 928 - 935. [Abstract] [Full Text] [PDF]

				U.-H. Stenman Standardization of Assays for Human Chorionic Gonadotropin Clin. Chem., May 1, 2004; 50(5): 798 - 800. [Full Text] [PDF]

				J.-L. Frendo, J. Guibourdenche, G. Pidoux, M. Vidaud, D. Luton, Y. Giovangrandi, D. Porquet, F. Muller, and D. Evain-Brion Trophoblast Production of a Weakly Bioactive Human Chorionic Gonadotropin in Trisomy 21-Affected Pregnancy J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 727 - 732. [Abstract] [Full Text] [PDF]

				G. E. Palomaki, G. J. Knight, M. M. Roberson, G. C. Cunningham, J. E. Lee, C. M. Strom, and R. Pandian Invasive Trophoblast Antigen (Hyperglycosylated Human Chorionic Gonadotropin) in Second-Trimester Maternal Urine as a Marker for Down Syndrome: Preliminary Results of an Observational Study on Fresh Samples Clin. Chem., January 1, 2004; 50(1): 182 - 189. [Abstract] [Full Text] [PDF]

				R. Pandian, J. Lu, and J. Ossolinska-Plewnia Fully Automated Chemiluminometric Assay for Hyperglycosylated Human Chorionic Gonadotropin (Invasive Trophoblast Antigen) Clin. Chem., May 1, 2003; 49(5): 808 - 810. [Full Text] [PDF]

				S. Birken, P. Berger, J.-M. Bidart, M. Weber, A. Bristow, R. Norman, C. Sturgeon, and U.-H. Stenman Preparation and Characterization of New WHO Reference Reagents for Human Chorionic Gonadotropin and Metabolites Clin. Chem., January 1, 2003; 49(1): 144 - 154. [Abstract] [Full Text] [PDF]

				K. Kosaka, H. Fujiwara, K. Tatsumi, S. Yoshioka, Y. Sato, H. Egawa, T. Higuchi, T. Nakayama, M. Ueda, M. Maeda, et al. Human Chorionic Gonadotropin (HCG) Activates Monocytes to Produce Interleukin-8 via a Different Pathway from Luteinizing Hormone/HCG Receptor System J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5199 - 5208. [Abstract] [Full Text] [PDF]